Holen Sie sich die Stockscreener-App
10.96
0.09%
0.01
Vorhandelsmarkt:
9.01
-1.95
-17.79%
Schlusskurs vom Vortag:
$10.95
Offen:
$11.07
24-Stunden-Volumen:
72,948
Relative Volume:
0.74
Marktkapitalisierung:
$940.61M
Einnahmen:
$106.66M
Nettoeinkommen (Verlust:
$15.16M
KGV:
117.22
EPS:
0.0935
Netto-Cashflow:
$6.37M
1W Leistung:
+4.18%
1M Leistung:
-1.62%
6M Leistung:
-27.70%
1J Leistung:
-41.37%
1-Tages-Spanne:
$10.61
$11.36
1-Wochen-Bereich:
$10.52
$11.36
52-Wochen-Spanne:
$8.26
$26.37
Gyre Therapeutics Inc Stock (GYRE) Company Profile
Firmenname
Gyre Therapeutics Inc
Sektor
Branche
Telefon
(619) 949-3681
Adresse
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Vergleichen Sie GYRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
10.96 | 940.61M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-29 | Fortgesetzt | Stephens | Overweight |
| 2021-02-10 | Eingeleitet | Piper Sandler | Overweight |
| 2020-05-21 | Eingeleitet | Raymond James | Outperform |
| 2019-01-04 | Eingeleitet | Oppenheimer | Outperform |
| 2018-02-12 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-08 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | Eingeleitet | Chardan Capital Markets | Buy |
| 2017-06-06 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-06-30 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 - MSN
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 By Investing.com - Investing.com Australia
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 14.4% in December - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $42,480 in stock - MSN
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Songjiang Ma Sells 2,000 Shares - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $42,480 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics president Songjiang Ma sells $11,156 in stock By Investing.com - Investing.com South Africa
Songjiang Ma Sells 1,057 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - MarketBeat
Gyre Therapeutics president Songjiang Ma sells $11,156 in stock - Investing.com
Barclays PLC Has $116,000 Stock Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells $22,336 in stock - Investing.com
Geode Capital Management LLC Has $3.81 Million Stock Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat
Leadership Changes at Gyre Therapeutics Amid Strategic Shift - TipRanks
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 3.2%Time to Sell? - MarketBeat
Gyre Therapeutics Reshapes Leadership: Appoints String Capital's Ping Zhang as Lead Director - StockTitan
Gyre Therapeutics president Ma Songjiang sells $49,600 in stock By Investing.com - Investing.com Australia
State Street Corp Grows Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells $49,600 in stock - Investing.com
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.4% Following Insider Selling - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.4% After Insider Selling - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $50,553 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $25,400.00 in Stock - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $50,553 in stock - Investing.com India
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $48,399 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $48,399 in stock - Investing.com India
Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Fmr LLC Takes $47,000 Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 3%What's Next? - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $43,440 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $21,640.00 in Stock - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $43,440 in stock - Investing.com
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpHere's Why - MarketBeat
Gyre therapeutics president Ma Songjiang sells $44,851 in stock By Investing.com - Investing.com Australia
Gyre therapeutics president Ma Songjiang sells $44,851 in stock - Investing.com
Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):